Concepedia
Statistics
Publications
33
Citations
2.2K
H-Index
25
Active since
1985
Affiliations
Novo Nordisk (Denmark)(Current)
Novo Holdings (Denmark)
Marselisborgcentret
University of Copenhagen
Christian-Albrechts-Universität zu Kiel
Peter H. Andersen is an author at Novo Nordisk (Denmark) specializing in pharmacology, neuropharmacology, and neuroscience.
Publications per year
1985–2022
The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action
Peter H. Andersen · European Journal of Pharmacology · 1989 · 348 citations · Full text
Life Sciences, Neuroscience, Pharmacology +14
Biochemical and Pharmacological Characterization of [<sup>3</sup>H]GBR 12935 Binding In Vitro to Rat Striatal Membranes: Labeling of the Dopamine Uptake Complex
Peter H. Andersen · Journal of Neurochemistry · 1987 · 231 citations
Medicine, Neuroscience, Pharmacology +16
<i>(R)‐N</i>‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake Carrier
Erik B. Nielsen, Ursula Sonnewald, Lars J. S. Knutsen et al. · Journal of Neurochemistry · 1990 · 228 citations
Life Sciences, Neuroscience, Pharmacology +5
A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum
Peter H. Andersen, Frederik C. Grønvald, Jens Aas Jansen · Life Sciences · 1985 · 143 citations · Full text
Life Sciences, Neuroscience, Pharmacology +16
Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain
Peter H. Andersen · European Journal of Pharmacology · 1988 · 110 citations · Full text
Medicine, Neuroscience, Pharmacology +14
1–5 of 33